Methimazolyl based diptych bicyclo-[3.3.0]-ruthenaboratranes by Ma, Chenxi & Hill, Anthony
Published in Dalton Transactions, 2019, 48, 1976-1992 
Available at : https://doi.org/10.1039/C8DT04813D  
ARTICLE 
Please do not adjust margins 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
Methimazolyl Based Diptych Bicyclo-[3.3.0]-Ruthenaboratranes 
Chenxi Maa and Anthony F. Hill*,a  
The reactions [RuCl(R)(CO)(PPh3)2] (R = CH=CHPh, Ph) with Na[H2B(mt)2]  (mt = N-methyl-2-mercaptoimidazolyl) transiently 
provide [Ru(R)(CO)(PPh3){k3-H,S,S’-H2B(mt)2}] which each evolve to the ruthenaboratrane  [Ru(CO)(PPh3)2{k3-B,S,S’-
BH(mt)2}](Ru®B)8.   The phosphine ligands may be selectively replaced to provide the  complexes [Ru(CO)(L)(PPh3){k3-B,S,S’-
BH(mt)2}] (L = CO, PMe2Ph)  and [Ru(CO)L2{k3-B,S,S’-BH(mt)2}] (L = PMe2Ph, P(OMe)3, L2 = Z-Ph2PCH=CHPPh2) with, in each 
case, retention of the ruthenium-boron dative bond.   
Introduction 
The term ‘metallaboratrane’ has been coined to draw analogy 
between the first such compound [Ru(CO)(PPh3){k4-B,S,S’,S”-
B(mt)3}] (mt = N-methylmercaptoimidazolyl),1-2 and Brown’s 
boratrane B(OCH2CH2)3N, given that both tricyclo-[3.3.3.0] cage 
structures include a trans-annular dative (polar covalent,4,5 
M®B cf. N®B) bond. (Chart 1). 
 
Chart 1. (a) Triptych and (b) Diptych boratranes and metallaboratranes. 
A large number of tricyclo-[3.3.3.0] metallaboratranes are 
now known based on cages in which the buttresses are variants 
on the original N-heterocycle (mt)6 or alternatively, 2-
phosphinoaryl bridges as pioneered by Bourissou.7 It might be 
argued that the presence of the trans-annular M®B interaction 
is in part a simple corollary of the geometric constraints 
imposed by the cage. Indeed, a recent attempt to assay the 
strength of this interaction through correlation of structural and 
spectroscopic data for an extensive series of the tri-buttressed 
(‘triptych’) ruthenaboratranes [Ru(CO)L{k4-B,S,S’,S”-B(mt)3}] (L 
= PPh3, CO, CNtBu, CNC6H2Me3, PMe3, PMe2Ph, P(OMe)3, 
P(OPh)3, PCy3) was generally unsuccessful,8 concluding that 
subtleties in the Ru®B bonding might be outweighed by inter- 
and intramolecular non-bonding interactions and cage strain. 
 Dibutressed (‘diptych’) boratranes are not only well-known9 
but also enjoy practical application in organic synthesis, most 
notably the B(O2CCH2)2NMe group found in BMIDA borates.10 
Within the field of metallaboratrane chemistry, a number of 
dibuttressed ‘diptych’ metallaboratranes have been isolated 
(Chart 1), however these remain comparatively rare, based 
either on N-heterocyclic buttresses11 or Bourissou’s 2-
phosphinoaryl system.7,12 To these may be added a small 
number of potentially triptych systems in which one buttress, 
however, remains pendant, at least in the solid state.11a,13 The 
majority of these involve the heavier (4d or 5d) group 9 and 10 
metals. A recurrent feature of the Ar-B(C6H4PR2)2 (R = iPr, Ph; Ar 
= Ph, C6H2Me3) system, in particular for 3d metals Fe, Co and Ni, 
is the h2-B,C(ipso) or ‘h3-B,C,C’-bora-allyl’ type coordination12a-
c,e of the B-aryl group. This is reminiscent of h3-benzyl ligands, 
and provides a means by which coordinative unsaturation at the 
metal may be alleviated. Diptych bicyclo-[3.3.0] 
metallaboratranes are of interest in that the metal-boron 
interaction is not constrained within the more restrictive 
tricyclo-[3.3.3.0] triptych geometry, allowing more confidence 
in interrogating the nature of the M®B bond. Furthermore, the 
more exposed M®B bond has been found to play a non-
innocent role in the activation of diatomic ligands such as CS,14 
H2,12a,c CO12a and N2.12e  
Given that the majority of diptych metallaboratranes have 
emerged within groups 9 and 10, with the only group 8 
examples being those based on Peters’ [Fe(CO)n{BPh(C6H4PiPr2-
2)2}]x–(n = 2,3; x = 0,1,2) ferraboratranes,12a-f we have now 
revisited the archetypal zerovalent5 ruthenium system to 
establish whether methimazolyl diptych ruthenaboratranes 
might also be viable. a. Research School of Chemistry, Australian National University, Acton, Canberra, 
A.C.T., Australia. 
†Electronic Supplementary Information (ESI) available: Selected characterisational 
spectra; Crystallographic information files CCDC  1881115-1881118 and 1881121 - 
1881125 relate to compounds discussed herein.  
Results and Discussion 
Synthesis and Reactivity 
The triptych ruthenaboratrane [Ru(CO)(PPh3){k4-B,S,S’,S”-
B(mt)3}] (1a) arose from the reactions of [RuCl(R)(CO)(PPh3)2] (R 
= Ph,15 CH=CHPh16) with Na[HB(mt)3],1a which were presumed 
to proceed via the complexes [Ru(R)(CO)(PPh3){HB(mt)3}] (R = 
Ph 2a, CH=CHPh 2b) although these could not be isolated. In 
contrast the reactions of [RuHCl(CO)(PPh3)3] with either 
Na[HB(mt)3] or Na[H2B(mt)2]17 afforded the stable hydrido 
complexes [RuH(CO)(PPh3){k3-H,S,S’-HBR(mt)2}] (R = H 2c, mt 
3).1b,18 The k3-H,S,S’ coordination mode has in the interim been 
found to be favourable for a wide range of transition metals and 
is especially prevalent within the chemistry of ruthenium.18,19 In 
extending studies on this mode of coordination, we recently 
described the series of complexes [RuR(CO)(PPh3){k3-H,S,S’-
H2B(mt)2}] (R = H 2c, Cl 4a, SeH 4b, SePh 4c, SiCl3 4d, SiMe3 4e, 
BO2C6H4 4f),18 none of which underwent the B–H activation step 
required for the installation of the metallaboratrane cage. In 
contrast, whilst the s-organyl derivatives [RuR(CO)(PPh3){k3-
H,S,S’-H2B(mt)2}] (R = Ph 4g, CH=CHPh 4h) could be 
spectroscopically observed (See Experimental), they eluded 
isolation due to their spontaneous evolution into what we now 
identify as the diptych ruthenaboratrane [Ru(CO)(PPh3)2{k3-
B,S,S’-BH(mt)2}](Ru®B)8 (5) (Scheme 1, Figure 1).20 
 
Scheme 1. Synthesis of a diptych ruthenaboratrane 
The initial synthesis of 5 involved employing the phenyl 
precursor [RuCl(Ph)(CO)(PPh3)2] which also resulted in the 
formation of a side product [Ru(Ph)(CO)(k2-N,S-mt)(PPh3)2] (6) 
and its removal by extensive washing with diethyl ether 
somewhat compromised the isolated yield of 5 (34%). The 
complex 6 has been described previously by Wilton-Ely 
including a crystallographic study of a dichloromethane 
solvate.21 The determination of the crystal structure of 
unsolvated 6 is presented in the experimental section but calls 
for no further comment. Given that the synthesis of 
[RuCl(Ph)(CO)(PPh3)2] requires the undesirable use of diphenyl 
mercury, an alternative more convenient and higher yielding 
synthesis of 5 was developed directly from mer-
[RuHCl(CO)(PPh3)3] (7). The reaction of 7 with ethynylbenzene 
to afford the trans-b-styryl complex 
[RuCl(CH=CHPh)(CO)(PPh3)2] is rapid and essentially 
quantitative,16 such that successive treatment of 7 with HCºCPh 
and Na[H2B(mt)2] returned 5 in 61% yield (3 g scale, ‘one pot’). 
The low symmetry of complex 5 (C1) follows from the 
appearance of two distinct methyl resonances in the 1H NMR 
spectrum (dH = 3.07, 3.33), as well as four imidazolyl peaks (dH = 
6.04, 6.15, 6.50, 6.58 d x 4, 3JHH = 1.8 Hz) indicating the chemical 
inequivalence of the two methimazolyl arms, which was also 
evident from 13C{1H} NMR data. Despite the broadening of the 
borohydride resonance by the quadrupolar boron nuclei (10B 
and 11B), the BH resonance was identified at dH = 4.07 (h.h.w. = 
209 Hz). A single boron resonance (11B{1H}: dB = 4.12) was 
observed in a region consistent with four-coordinate metal-
bound boron.1,2 The two phosphine environments were 
manifest as resonances at dP = 19.3 and 52.7, where the 
broadness of the latter resonance was indicative of 
coordination trans to the boron. The composition of complex 5 
was further supported in the HR-ESI(+ve ion, MOH matrix) mass 
spectrum with a peak corresponding to a [M–CO+OMe]+ adduct 
(m/z = 895.1592). 
The formulation of 5 was confirmed by an X-ray 
crystallographic study, the results of which are summarised in 
Figure 1. This reveals a distorted octahedral coordination at 
ruthenium and distorted tetrahedral geometry about boron 
with angles in the range of 104.7(12)–123.2(13)°. The Ru1–B1 
bond length of 2.2463(16) Å is somewhat longer than found in 
the corresponding triptych analogue 1a (2.161(5) Å; D = 17 
e.s.d.), falling outside the range previously observed for Ru®B 
bonds (2.157(6) - 2.184(6)Å).1,8 
 
Figure 1. Molecular structure of 5 in a crystal of 5.Et2O (Hydrogen atoms and Et2O solvent 
omitted, phenyl  groups simplified, 50% displacement ellipsoids). Data collected using 
both Mo-Ka and Cu-Ka radiation Selected bond lengths (Å) and angles (°) derived from 
Cu-Ka data: B1–Ru1 2.2463(16), B1–H1 1.17(2), Ru1–P1 2.4766(4), Ru1–P2 2.3045(4), 
Ru1–C1 1.8336(16), H1–B1–Ru1 123.3(13), N2–B1–H1 104.7(12), N3–B1–H1 106.1(12), 
B1–Ru1–P1 166.36(4), B1–Ru1–P2 84.13(4), P1–Ru1–P2 108.061(13). Inset = Space filling 
representations showing PPh3 ligands in lilac and green. 
Notably, the two Ru–P bonds are very significantly different 
in length (430 e.s.d.), where the phosphine trans to boron 
exhibits a far longer bond than that trans to sulfur. The 
comparatively pronounced trans influence of M®B bonds has 
been noted previously for the complexes [Rh(PMe3)2{B(mt)3}]+, 
[PtI2{B(mt)3}] and [Fe(CO)2{B(mttBu)3}] wherein the boron and 
one thione donor are trans to identical s-donor (PMe3),22 (s+p) 
donor (iodide)23 or p-acceptor (CO)24 ligands. 
 The formation of a minor side product (8, ca 1%) was 
observed to accompany the isolation of 5 when the ‘one-pot’ 
procedure was used and whilst this was only isolated in 
sufficient quantity for crystallographic characterisation, details 
are included here as they provide two relevant points of 
interest. The product was identified as the alkynyl complex 
[Ru(CºCPh)(CO)(PPh3){k3-H,S,S’-H2B(mt)2}] (8, Figure 2) which is 
akin to the complexes 2c and 4a-f but distinct from 4g and 4h in 
being a thermally stable s-organyl derivative that does not 
evolve to 5.  
 
Figure 2. Molecular structure of 8 in a crystal of 8.CHCl3 (Hydrocarbon hydrogen atoms 
and CHCl3 solvent omitted, phenyl  groups simplified, 50% displacement ellipsoids). 
Selected bond lengths (Å) and angles (°): B1...Ru1 2.740(2), B1–H1 1.24(4), B1–H2 1.19(4), 
Ru1–H1 1.74(4), Ru1–P1 2.3228(6), Ru1–C1 1.864(2), Ru1–C2 2.028(3), C2–C3 1.200(4), 
C3–C4 1.448(3), B1– H1–Ru1 134(3), H1–Ru1–C2 173.3(14), S2–Ru1–P1 176.25(2), S1–
Ru1–P1 87.20(2), S1–Ru1–S2 89.82(2). 
Notably, treating 5 with an excess of ethynylbenzene does 
not lead to formation of 8 under the conditions in which it was 
first isolated. This leaves two possible mechanistic routes to 8, 
both of which involve the occasionally observed cleavage of 
ruthenium alkenyls by terminal alkynes to provide s-alkynyl 
derivatives, a process that underpins the catalytic dimerization 
of terminal alkynes to provide butenynes.25 The first possibility 
is that a small amount of unreacted [RuHCl(CO)(PPh3)3] 
remained at the time Na[H2B(mt)2] was added (the alkyne 
hydroruthenation is also a reversible process), being converted 
to 2c followed by alkyne hydrometallation to generate 4h which 
then undergoes (net) s-metathesis with ethynylbenzene to 
generate the alkynyl complex 8. This may be excluded because 
it could be shown in separate experiments that pre-isolated 2c 
is unreactive towards HCºCPh under these conditions. Under 
more forcing conditions, with an excess of HCºCPh, the hydride 
precursor [RuHCl(CO)(PPh3)3] affords [RuCl{C(CºCPh)=CHPh}-
(CO)(PPh3)2],26 which is an effective alkyne dimerization 
catalyst.27 The yet to be isolated species 
‘RuCl(CºCPh)(CO)(PPh3)n’ (n = 2,3) being plausible resting states 
that might react with Na[H2B(mt)2] to afford 8. The mild 
conditions under which 8 forms would seem to argue against 
this. The final mechanism, which we consider the most 
plausible, involves a reaction of 4h with HCºCPh to provide 8 
and styrene, in a process that operates to a very modest extent 
in competition with the metallaboratrane formation. 
 
Scheme 2. Mechanism conjecture to account for the formation of a borato alkynyl 
complex 8. 
The structural features of 8 (Figure 2) correlate well with 
those reported for the analogous complexes 2c and 4a-4f and 
call for little comment other than to note that the Ru…B 
separation of 2.740(2)Å falls within the range previously 
observed (cf. 2.651–2.897 Å), as does the less precisely 
determined B–H–Ru angle of 134(3)° (cf. 128–138°).18 The Ru–C 
and C–C bonds are also well within the ranges observed for the 
copious structural data available for octahedral ruthenium(II) 
alkynyls. 
The potential of the M®B association to engage directly in 
reactions has been long of interest. In particular, the question 
of interconversion between coordination modes k3-B,S,S’ and 
k3-H,S,S’ via hydride migration from the metal centre was first 
demonstrated when the platinaboratrane [PtH{P(C6H4Me-
4)3}{B(mt)3}]Cl was shown to undergo phosphine substitution by 
PMe3 or PEt3 accompanied by reconstitution of the k3-H,S,S’-
HB(mt)3 coordination.25 In the interim, further examples of 
hydrogenation of M®B bonds have emerged,11h,i,12d,f,i,13b some 
of which involve heterolytic cleavage of dihydrogen itself to 
generate metal hydride (M–Hd+) and boron-hydride (M–Hd–) 
units.  Taken together, the complexes [Co(H2){k4-B,P,P’,P”-
B(C6H4PiPr2-2)3]12e and [MH(CO)x{k3-H,P,P’-
HB(C6H2Me3)(C6H4PiPr2)2}] [M = Ni, x = 0;12c M = Fe x = 212a) 
provide an elegant indication of the subtleties at play along the 
dihydrogen cleavage trajectory. 
As noted above, 5 fails to react with ethynylbenzene to 
afford 8 and in a similar manner, no reaction is observed 
between 5 and HBO2C6H4 (HBCat), dihydrogen, or 
pentamethylcyclopentadiene even though plausible products of 
such reactions [RuH(CO)(PPh3){H2B(mt)2}] (2c), 
[Ru(BCat)(CO)(PPh3){H2B(mt)2}] (4f)18 and [Ru{H2B(mt)2}(h-
C5Me5)] are all known and stable.19h In contrast, treating 5 with 
one equivalent of hydrogen chloride results in extensive 
decomposition and degradation of the cage such that a mixture 
of products was obtained within one hour (distribution invariant 
over 24 hours) with complete consumption of 5. Numerous 
resonances were observed in the 31P{1H} NMR spectrum (dP = 
19.1, 28.1, 35.7, 45.2, 50.0 and 55.2) none of which 
predominated or corresponded to the anticipated chloro 
complex [RuCl(CO)(PPh3){H2B(mt)2}] (4a: dP = 36.3; dH =  –18.11; 
dB = –7.36).18 Attempts to identify the products formed through 
crystallisation of the crude mixture from chloroform/n-pentane 
afforded complexes 9 and 10 as a mixture, which could be 
further purified to exclusively isolate 10 (Scheme 3). 
 
Scheme 3. Metallaboratrane degradation processes. 
The formulations of complexes 9 (Figure 3) and 10 (Figure 4) 
were confirmed by X-ray diffraction studies, however 
unequivocal syntheses were not explored due to their rather 
mundane nature. 
The key bond lengths and angles of 9 and 10 are consistent 
with other reported structures of thione bound N-methyl-2-
mercaptoimidazole ligands on Ru(II) centres.21,29 For example, 
the Ru–S bond lengths of 2.3845(6) Å in 9 and 2.4128(12), 
2.4240(11) Å in 10 show little deviation from the range 
established for published complexes (2.391–2.553 Å). Similarly, 
the Ru1–S1–C2 angle of 115.59(9)° in 9 or 112.20(16) and 
112.46(14)° for 10 lie within the previously observed range 107–
119°. The molecular structure of 10 depicted in Figure 4 is 
consistent with spectroscopic data. The IR spectrum shows one 
CO absorption (1961 cm-1) while the symmetric mutually trans 
coordination of two methimazole groups was inferred through 
1H NMR integration relative to the triphenylphosphine co-
ligand. The triphenylphosphine ligand of isolated complex 10  
 
Figure 3. Molecular structure of 9 in a crystal of 9.CHCl3 (CHCl3 solvent omitted, phenyl  
groups simplified, 50% displacement ellipsoids). Selected bond lengths (Å) and angles (°): 
Ru1–Cl1 2.4351(6), Ru1–Cl2 2.4841(6), Ru1–S1 2 .3845(6), Ru1–P1 2.3982(6), Ru1–P2 
2.4239(6), Ru1–C1 1.833(3), Ru1–S1–C2 115.59(9), S1–Ru1–Cl1 165.87(2), P1–Ru1–P2 
175.03(2), C1–Ru1–Cl2 174.40(8). 
gives rise to a resonance at dP = 45.1 and by a process of 
elimination from the spectrum of the crude mixture, 9 was 
identified as being responsible for the resonance at dP = 19.1. 
The formulations of both complexes were further confirmed by 
HR ESI(+ve ion) mass spectrometry, with isotopic clusters 
corresponding to [M – Cl]+ at m/z = 803.0754 for 9 and 655.0102 
for 10. 
  
Figure 4. Molecular structure of 10 in a crystal of 10.CHCl3 (Hydrocarbon hydrogen atoms 
and CHCl3 solvent omitted, phenyl  groups simplified, 50% displacement ellipsoids). 
Selected bond lengths (Å) and angles (°): Ru1–Cl1 2.4804(11), Ru1–Cl2 2.4763(11), Ru1–
S1 2.4128(12), Ru1–S2 2.4240(11), Ru1–P1 2.3110(11), Ru1–C1 1.827(5), Ru1–S1–C11 
112.20(16), Ru1–S2–C15 112.46(14), S1–Ru1–S2 169.21(4), P1–Ru1–Cl2 175.58(4), C1–
Ru1–Cl1 170.99(14). 
The platinaboratrane [Pt(PPh3){k4-B,S,S’,S’’-
B(mt)3}](Pt®B)10 undergoes oxidative addition with Br2 or I2 to 
generate Pt(II) complexes [PtX2{k4-B,S,S’,S’’-B(mt)3}](Pt®B)8 (X 
= Br, I) with retention of the Pt®B bond.28 In contrast, both the 
ferraboratrane [Fe(CO)2{B(mttBu)3}]24 and nickelaboratrane 
[NiBr{B(mttBu)3}]30 react with oxidants with rupture of the metal-
boron bond and formation of B-functionalised 
tris(mercaptoimidazolyl)borate ligands. The reactions of 5 with 
either elemental bromine or iodine proved to be complex (> 10 
products), with no single product predominating according to 
spectroscopic analysis (31P NMR) of the crude reaction mixture 
or samples subjected to fractional crystallisation. Group 8 
(M®B)8 metallaboratranes upon oxidative addition would be 
expected to provide d6 metal centres, i.e., devoid of a pair of 
electrons housed in an orbital of metal-ligand s-symmetry and 
therefore unable to sustain a dative bond to boron. In the case 
of Parkin’s (Fe®B)8 system,24 which is able to presumably 
traverse single-electron transfer radical pathways more easily 
than ruthenium, addition of halogens across the Fe®B bond is 
the preferred outcome. Owen’s report on the group 10 diptych 
metallaboratranes [M{BH(mp)2}(PPh3)] (M®B)10 ( M = Pt, Pd; 
mp = 2-mercaptopyidyl), suggests a fine balance between the 
coordination flexibility of the “BH(mp)2” group.11e The 
“BH2(mp)2” unit typically coordinates facially, however in these 
metallaboratranes the nearly trans-disposed sulfurs exhibit 
more meridional-like k3-B,S,S’ coordination (S–M–S = 161.14(3) 
Pt, 158.88(2)° Pd). Inspired by this result, 5 was treated with 
hydride abstractor [CPh3][PF6] to assess the potential of 5 to 
relax to meridional coordination upon boron hydride 
abstraction. Within two hours, the solution IR spectrum (THF) 
indicated a significant shift of the nCO band from 1899 cm-1 in 5 
to 1931 and 1972 cm-1, consistent with the conversion of a 
neutral to cationic complex. The conspicuous absence of a BH 
stretching band was also noted in the IR spectrum. Both the 1H 
and 31P{1H} NMR spectra revealed broad resonances. In the 
crude 31P{1H} spectrum, the dominant product was identified at 
dP = 39.6 accompanied with distinct resonances corresponding 
to PF6 (dP = ‒142.9) and free PPh3. The broadness of the latter 
may imply the occurrence of rapid exchange processes. The 
resonance at dP = 39.6 persisted following purification through 
washing with diethyl ether. Attempts to identify the product 
through X-ray diffraction analysis of crystals obtained from slow 
evaporation of a benzene/n-pentane solution afforded the salt 
[RuF(Hmt)2(CO)(PPh3)2]PF6 [11]PF6 (Scheme 3, Figure 5). 
 
Figure 5. Molecular structure of [11]+ in a crystal of  [11]PF6.C6H6 (benzene solvent and 
counter anion omitted, aryl hydrogen atoms omitted, phenyl groups simplified, 50% 
displacement ellipsoids). Selected bond lengths (Å) and angles (°): Ru1–F1 2.098(2), Ru1–
S1 2.4338(10), Ru1–S2 2.4238(11), Ru1–P1 2.3970(9), Ru1–P2 2.4277(10), Ru1–C1 
1.818(4), F1–Ru1–C1 177.70(15), S1–Ru1–F1 91.60(7), S2–Ru1–F1 92.30(7). Inset = view 
normal to the P1–Ru1 vector illustrating bifurcated NH…F…HN hydrogen bonding. 
The cation of this salt features a terminal ruthenium fluoro 
ligand, the coordination of which is stabilised by bifurcated 
hydrogen bonding to two N-H groups from adjacent Hmt co-
ligands (NH…F = 1.627, 1.764 Å). The fluoride is coordinated 
trans to the carbonyl ligand, as invariably observed for 
octahedral ruthenium fluoro-carbonyl complexes, presumably 
to maximise captodative interactions between the p-donor and 
p-acidic characters of the two ligands. The Ru–F distance of 
2.098(2) Å lies within the range established by simple 
octahedral ruthenium complexes, despite the intramolecular 
hydrogen bonding.31 
In contrast to the analogous 1a which carries only one 
triphenylphosphine, the two triphenylphosphines within 
complex 5 each present potential sites for substitution and the 
cis disposition of these results in some inter-ligand repulsion 
which presumably also contributes to steric impetus in addition 
to the now recognised trans influence of M®B interactions. 
Accordingly, this aspect was investigated through ligand 
substitution reactions. Facile and clean substitution of 
triphenylphosphine was achieved by passing CO through a 
solution of 5 in THF for 15 minutes to selectively yield the 
symmetrical cis-dicarbonyl complex [Ru(CO)2(PPh3){k3-B,S,S’-
BH(mt)2}] (12), with no evidence for the asymmetrical isomer 
12x (Scheme 4). 
 
Scheme 4. Metallaboratrane carbonylation. 
The reaction proceeded with increased symmetry (C1 to  Cs) 
as inferred from the 1H NMR spectrum, manifest by the 
replacement of the two distinct methyl resonances in 5 by one 
resonance in 12 (dH = 3.43). The four independent olefinic 
proton resonances for 5 similarly simplified to two 
environments at dH = 6.62 and 6.69 [ABCD to AA’BB’]. The 
13C{1H} NMR spectrum contained fewer resonances, as 
expected for Cs 12 compared to C1 5, most notably, the 
appearance of a single carbonyl resonance (dC = 202.9, d, 2JCP = 
2.4 Hz). Notably, only one phosphine environment was present 
in the 31P{1H} NMR spectrum of 12 (dP = 20.1), the broadness of 
which is consistent with coordination trans to the boron. The 
spectrum measured in situ included a resonance due to 
liberated PPh3 which was sharp, confirming that exchange with 
the coordinated PPh3 did not occur on the 31P{1H} NMR 
timescale (161 MHz at 25 °C). Furthermore, an absence of the 
resonance at dP = 52.7 corresponding to the phosphine of 5 
trans to sulfur suggested replacement at this position by the CO 
ligand. Replacement of one phosphine by CO was further 
confirmed by IR spectroscopy, which showed two nCO 
associated bands (CH2Cl2: 1913, 1984 cm-1).  
The X-ray diffraction analysis of single crystals of 12.CHCl3 
shown in Figure 6 was consistent with the symmetrical 
formulation inferred from spectroscopic data. In contrast to 5, 
a space-filling diagram of 12 reveals less steric encumbrance 
about the equatorial plane occupied by the two CO ligands. 
Nevertheless, it is noteworthy that the carbonyl ligands appear 
to be displaced towards the Ru1-B1–H1 unit, a result that we 
attribute to an inter-ligand interaction in which this electron 
rich group donates into the CO p* orbitals. The mitigation of 
steric congestion associated with replacement at the equatorial 
phosphine by CO is expected to be greater than at the (BRu) 
axial position, which may provide a rationale for the observed 
regioselectivity. In addition, the introduction of p-acidic CO is 
electronically favourable in further relieving the electron 
density at the p-basic electropositive Ru(0) metal centre. 
Certainly, location of the two strongest p-acids (CO) trans to the 
two strongest p-donors (mt) would be expected to maximise p-
captodative effects. The geometry of the ultimate product 
would seem kinetically counter-intuitive given the clear trans 
influence that is apparent in the molecular structure of 5. That 
said, it should be noted that a dissociative pathway would 
involve a five-coordinate intermediate, the lifetime of which 
may well be sufficient as to allow pseudo-rotation to reposition 
the vacant site cis to the boron, i.e.,  the final stereochemistry 
adopted need not necessarily reflect the site of initial 
dissociation. This is in contrast to substitution reactions of 1a 
wherein the triptych cage with more constrained geometry is 
less able to undergo rearrangement. Additional details of the 
molecular structure of 12 will be discussed collectively with 
further examples below. 
 
Figure 6. Molecular structure of 12 in a crystal of 12.CHCl3 (Aryl hydrogen atoms  and 
CHCl3 solvate omitted, phenyl groups simplified, 50% displacement ellipsoids). Selected 
bond lengths (Å) and angles (°): B1–Ru1 2.237(2), B1–H1 1.03(4), Ru1–P1 2.4740(5), Ru1–
C1 1.861(2), Ru1–C2 1.855(2), H1–B1–Ru1 117(2), B1–Ru1–P1 173.72(6), B1–Ru1–C1 
82.18(9), B1–Ru1–C2 81.16(9), C1–Ru1–C2 91.77(10). Insets = view along B1–Ru1 vector 
and representation of angle (18.3°) between the S1–Ru1–S2 (red) and C1–Ru1–C2 (blue) 
planes.  
In contrast to the reversible CO coordination in 1a, 
subjecting a crude sample of 12 to vacuum did not result in 
reformation of 5. The persistence of complex 12 was instead 
noted in the 1H and 31P{1H} NMR spectra, which suggested 
irreversible coordination of the CO ligand. Together these 
observations suggest that coordination of CO trans to the Ru®B 
linkage is less favourable than coordination trans to the p-basic 
thione donors. 
Ligand exchange investigations were extended to consider a 
range of electronically and sterically variant phosphines. The 
reaction of 5 with an excess of PMe3 proceeded cleanly within 
one hour to give the product of mono-substitution 
[Ru(CO)(PMe3)(PPh3){BH(mt)2}], the nature of which was 
inferred from NMR spectroscopic data. The 31P{1H} NMR 
spectrum revealed the shift to higher frequency of both 
phosphine resonances relative to 5, where the broad peak at dP 
= ‒29.6 suggests the triphenylphosphine ligand was located 
trans to the boron, with the doublet at dP = 58.7 (2JPP = 11.3 Hz) 
corresponding to coordinated PMe3. Integration of the 31P{1H} 
NMR resonances confirmed the liberation of one 
triphenylphosphine. The inferred product 
[Ru(CO)(PMe3)(PPh3){BH(mt)2}], however, eluded isolation, 
despite the promisingly clean NMR spectra acquired for the 
crude reaction mixture. Failure to isolate the product might 
reflect the lability and/or volatility of PMe3. Therefore, 
investigations were followed up with the less volatile PMe2Ph, 
which has electronic and steric properties not dissimilar to 
PMe3. As with the reactivity observed with PMe3, complex 5 was 
found to react with an excess of PMe2Ph at room temperature 
to afford a single substitution product, 
[Ru(CO)(PMe2Ph)(PPh3){BH(mt)2}] 13 (Scheme 5). 
 
Scheme 5. Phosphine substitution reactions of 5. 
Interestingly, substitution of the second phosphine was not 
observed spectroscopically under these mild reaction 
conditions, despite the presence of excess PMe2Ph. The 
spectroscopic data resemble those observed for the complex 
[Ru(CO)(PMe3)(PPh3){BH(mt)2}]. The broad resonance at dP = ‒
17.2 was attributed to the PMe2Ph ligand coordinated trans to 
the Ru®B bond, while the relatively sharp doublet at dP = 56.9 
(1JPC = 11.3 Hz) was assigned to the larger PPh3 ligand 
coordinated trans to one thione. The use of PMe2Ph over the 
more symmetrical PMe3 is advantageous in that the two methyl 
groups provide an indication of the local symmetry of the 
complex. The asymmetric (C1) nature of 13 was thus evident 
from 1H NMR spectroscopy with the diastereotopic methyl 
groups of PMe2Ph manifested as chemically inequivalent 
doublets at dH = 1.43 (1JHP = 5.3) and 1.28 (1JHP = 5.5 Hz); whilst 
the remaining 1H signals show similarity to those of 5. Although 
crystals of 13 suitable for X-ray diffraction studies were not 
obtained, the formulation of 13 was supported by the 
identification of the [M + H]+ peak at m/z = 769.1099 in the ESI-
MS.  
The overnight acquisition of the 13C{1H} NMR spectrum of a 
pure sample of 13 revealed several (≈6) resonances in the 
region typical of N-methyl mt substituents (dC = 33.5–34.2). 
These appeared as distinct resonances in the 1H NMR spectrum 
(measured after 13C data acquisition, See ESI Figure S1) at dH = 
3.44 and 3.48 (minor) and at dH = 3.30 and 3.35 (major). The 
decomposition of 13 into these products occurred over 10 
minutes from dissolution in CDCl3, reaching equilibrium at room 
temperature to provide a relative ratio of 2:3:5 for 13, the minor 
product, and the major product. The formation of these 
products was initially suspected to be due to the residual acidity 
of the CDCl3 solvent. However, similar patterns emerged when 
the less acidic CD2Cl2 was used as the solvent. 
 
Figure 7. Molecular structure of 14 in a crystal of 14 (Phenyl hydrogen atoms omitted, 
phenyl groups simplified, 50% displacement ellipsoids). Selected bond lengths (Å) and 
angles (°): B1–Ru1 2.253(4), B1–H1 1.09(6), Ru1–P1 2.4095(9), Ru1–P2 2.2876(9), Ru1–
C1 1.821(4), H1–B1–Ru1 120(3), B1–Ru1–P1 171.51(11), B1–Ru1–P2 88.00(11), B1–Ru1–
C1 88.78(16), P1–Ru1–P2 99.57(3).. 
To encourage conversion of 13 to the products previously 
observed in CDCl3, an aliquot of the crude reaction mixture of 
13 in THF was briefly (≈ 2 minutes) heated to reflux. The NMR 
spectra showed the clean partial conversion of 13 to complex 
[Ru(CO)(PMe2Ph)2{BH(mt)2}] (14), with no evidence for the 
other decomposition product or the Cs-symmetric isomer of 14, 
which remains unknown. Full conversion of 13 to 14 was 
achieved on a preparative scale by heating in refluxing THF for 
18 hours (Scheme 5, Figure 7). The formation of 14 was 
accompanied by an increased complexity of the methyl region 
(dH = 1.27–1.48, due to the presence of two chemically 
inequivalent PMe2Ph ligands, each with a pair of diastereotopic 
P-CH3 substituents with associated resonances each being 
doublets, (two doublets would be expected for the Cs isomer of 
14). Four distinct P-CH3 resonances were also present in the 
13C{1H} NMR spectrum of 14. Two of the PMe2Ph methyl groups 
couple to the chemically inequivalent phosphines in a doublet 
of doublet multiplicity (dC = 15.6, 1JCP = 31.2, 3JCP = 3.3; 18.6, 1JCP 
= 32.3, 3JCP = 4.2 Hz), while the other two P-CH3 resonances 
appear only as doublets (dC = 16.3, 1JCP = 13.6; 19.4, 1JCP = 16.2 
Hz), presumably reflecting a Karplus-type C–P–Ru–P dihedral 
angular dependence.32 Although rotation about the Ru–P bond 
in solution is expected, the steric properties of the phenyl 
moiety may well dictate conformational preferences. 
Coordination of two PMe2Ph ligands was further ascertained by 
the respective sharp doublet and broad singlet phosphine 
environments at dP = 14.5 (2JPP = 12.3) and –16.4, respectively, 
in the 31P{1H} NMR spectrum.  
By a process of elimination in the 1H and 31P{1H} NMR 
spectra of resonances corresponding to 13 and 14, the third 
product formed from the ambient temperature decomposition 
of 13 in CDCl3 is suggested to be the isomerised complex 13x 
(Scheme 5). The methyl resonances in Figure ESI-S1 consist of 
two distinct doublets for the PMe2Ph ligand (dH = 1.23, 1.45, 2JHP 
= 8.5 Hz), whereas the downfield resonances (dH = 3.19, 3.24) 
correspond to the chemically inequivalent N-methyl groups of 
the HB(mt)2 backbone coordinated to a C1 symmetric centre. 
The olefinic signals of all three products reside in a similar 
chemical shift range of 6.40–6.58 ppm, which occluded the 
identification of the resonances attributable to 13x. The two 
dominant resonances in the 31P{1H} NMR spectrum further 
support the assignment of 13x. Consistent with the other 
ruthenaboratranes discussed herein, the two phosphine 
associated resonances resolve as a broadened signal at dP = 22.0 
and a sharp doublet at dP = 12.9 (2JPP = 11.4 Hz), which were 
assigned to PPh3 and PMe2Ph, respectively. 
Compared to PMe3 and PMe2Ph, trimethylphosphite has a 
smaller steric profile and greater p-acidity. Treatment of 5 with 
a three-fold excess of P(OMe)3 for 18 hours at room 
temperature yielded the product of double substitution, the 
complex [Ru(CO){P(OMe)3}2{BH(mt)2}] 15. Whilst the crude 
31P{1H} NMR spectrum revealed several (≈10) resonances, 
complex 15 was evident as the dominant species and could be 
purified through recrystallisation from diethyl ether and n-
pentane. The formulation of 15 was established by NMR 
spectroscopy, mass spectrometry and a single crystal X-ray 
diffraction study (Figure 8). 
In addition to the characteristic resonances resulting from 
the {BH(mt)2} moiety in the 1H NMR spectrum, doublets at dH = 
3.67 (3JHP = 11.1 Hz) and 3.56 (3JHP = 10.8 Hz), are consistent with 
the coordination of two chemically inequivalent P(OMe)3 
ligands. Given the electronegatively inductive (I–) effects of the 
methoxy substituents, the two P(OMe)3 resonances were 
observed as a doublet at dP = 151.1 (2JPP = 19.4 Hz) and a broad 
singlet at dP = 153.7, both as expected, downfield compared to 
complexes 5 and 12-14 of this series. The replacement of both 
triphenylphosphine ligands in 5 by P(OMe)3 was further 
demonstrated in the 13C{1H} NMR spectrum by an absence of 
signals in the aromatic region and the appearance of two 
resonances in the methoxy region (dC = 50.8, 52.0). The effect 
of the quadrupolar boron nuclei appears to extend to the 
methyl carbon resonance of the P(OMe)3 ligand to which it is 
trans coordinated, which results in broadening for the former 
resonance. Meanwhile, the latter resonance for the equatorial 
phosphite ligand remains unaffected, appearing as a sharp 
doublet (2JPP = 5.9 Hz). 
 
Figure 8. Molecular structure of 15 in a crystal (50% displacement ellipsoids, one of three 
crystallographically distinct molecules shown ). Selected bond lengths (Å) and angles (°): 
B1–Ru1 2.252(3), B1–H1 1.17(5), Ru1–P1 2.3604(8), Ru1–P2 2.2341(8), Ru1–C1 1.835(3), 
H1–B1–Ru1 122(3), B1–Ru1–P1 173.33(9), B1–Ru1–P2 86.67(9), B1–Ru1–C1 81.66(13), 
P1–Ru1–P2 99.56(3). 
A notable difference in the reactivity of 5 with PMe2Ph or 
PMe3 compared to P(OMe)3 is the ease of the second PPh3 
substitution. Single substitution predominately occurs with the 
electron rich alkyl phosphines at room temperature, and 
introduction of the second equivalent can be achieved only at 
elevated temperatures. In contrast, substitution with P(OMe)3 
occurs readily at room temperature with replacement of both 
triphenylphosphines. This is most likely a corollary of the 
greater capacity of p-acidic P(OMe)3 to stabilize the electron 
rich Ru(0) centre cf. PPh3. This is reflected by the IR shift to 
higher frequency from 1908 cm-1 in 5 to 1921 cm-1 in 15. 
Furthermore, replacement of the bulky PPh3 with P(OMe)3 is 
sterically favourable (θT° 145 cf. 107°, respectively). 
Previous investigations on triptych ruthenaboratranes8 
derived from 1a revealed that [Ru(CO)(PCy3){B(mt)3}] could not 
be isolated from the reaction of 1a with PCy3 because an 
equilibrium between PPh3 and PCy3 coordination developed. An 
alternative approach utilised the complex [RuCl(Ph)(CO)(PCy3)2] 
in a direct reaction with Na[HB(mt)3] which obviated the 
competitive presence of PPh3.  Similar synthetic strategies were 
explored toward the complexes [Ru{BH(mt)2}(CO)(PCy3)(PPh3)] 
and [Ru{BH(mt)2}(CO)(PCy3)2] without success. It should be 
noted that whilst the sterically congested cis-Ru(PCy3)2 
fragment is understandably rare, it is not unknown.33 The room 
temperature reaction of 5 with two equivalents of PCy3 in THF 
for 20 hours yielded mainly starting material and numerous 
minor products (~10 resonances in the 31P{1H} NMR spectrum). 
Heating under reflux for four hours facilitated further 
development of these resonances with the concurrent 
appearance of free PPh3 and absence of the starting material. 
However, the anticipated complex 
[Ru{BH(mt)2}(CO)(PCy3)(PPh3)] and other products could not be 
conclusively identified. Further attempts with a stoichiometric 
amount of PCy3 at room temperature and at reflux, in Et2O and 
THF, showed either no reaction or produced 1H and 31P{1H} NMR 
spectra that were similarly abundant in unidentifiable 
resonances. No dynamic phosphine exchange was inferred from 
the sharp resonance for the liberated PPh3.  
To eliminate possible complication of mixed PPh3/PCy3 
coordination, the synthesis of the PCy3 analogue of 5 was 
pursued through reaction of Na[H2B(mt)2] with 
[RuPhCl(CO)(PCy3)2] in THF. The solution IR spectrum in THF of 
the crude reaction mixture displays a CO band of low stretching 
frequency 1898 cm-1, amongst others (nCO = 1918, 1988 cm-1). 
This is indicative of ruthenium in the zero-oxidation state and 
falls within the range 1877–1921 cm-1 established for the 
ruthenaboratranes synthesised thus far and whilst these IR data 
were promising, the presence of four sharp resonances of equal 
intensity in the 31P{1H} NMR spectrum suggested the absence of 
phosphine coordination trans to the boron. Despite numerous 
crystallisation experiments, only amorphous powder unsuitable 
for X-ray diffraction studies was obtained. The complications 
associated with the introduction of PCy3 may be sterically 
and/or electronically disfavoured cf. PPh3. The steric bulk of the 
PCy3 ligand is considerably greater than that of PPh3, and 
therefore it may be unfavourable to adjacently accommodate 
two of these ligands around the ruthenium centre. From the 
substitution reactions investigated thus far, the substitution 
process appears to be most facile and favoured for p-acidic 
ligands, such that the s-basicity of the PCy3 ligand may disfavour 
its coordination to the electron rich Ru(0) centre. 
The replacement of both PPh3 ligands in 5 in the synthesis of 
complexes 14 and 15 led to the natural extension of the 
substitution reactivity to the inclusion of bidentate ligands. 
Given the cis arrangement of the PPh3 ligands in 5, Z-1,2-
bis(diphenylphosphino)ethylene (dppen), was envisaged as a 
suitable bidentate ligand to ensure chelation, rather than 
formation of bridged binuclear species as might be anticipated 
for the more commonly employed 1,2-
bis(diphenylphosphino)ethane (dppe) ligand. The conversion of 
5 to [Ru{BH(mt)2}(CO)(Ph2PCH=CHPPh2)] 16 took place in THF 
under reflux for 43 hours, evident by the development of two 
downfield resonances at dP = 70.6 (d, 2JPP = 8.1) and 50.8 (broad) 
in the 31P{1H} NMR spectra. The vinylic hydrogen resonances of 
the phosphine were obscured within the aromatic region but 
could be located from 1H13C HSQC experiments as multiplets at 
dH = 7.91 and 7.97. The corresponding 13C{1H} shifts appear as 
two doublet of doublet resonances, respectively at dC = 148.1 
(1JCP = 26.6, 2JCP = 26.6) and 149.0 (1JCP = 35.8, 2JCP = 45.5). The C1 
symmetry of 16 and the rigidity of the ethylene backbone 
renders each phenyl on the dppen chelate inequivalent. The 
molecular structure of 16 was confirmed by an X-ray diffraction 
study, as depicted in Figure 9 and discussed below. 
 
 
Figure 9. Molecular structure of 16 (aryl hydrogen atoms omitted, phenyl groups 
simplified, displacement ellipsoids shown at 50%). Selected bond lengths (Å) and angles 
(°): B1–Ru1 2.231(2), B1–H1 1.09(4), Ru1–P1 2.3636(5), Ru1–P2 2.2719(5), Ru1–C1 
1.848(2), H1–B1–Ru1 121(2), B1–Ru1–P1 175.39(6), B1–Ru1–P2 91.81(6), B1–Ru1–C1 
86.26(9), P1–Ru1–P2 85.29(2) 
The triptych ruthenaboratrane 1a undergoes clean and 
irreversible substitution of the PPh3 ligand by isonitriles CNR (R 
= tBu, C6H2Me3-2,4,6, C6H3Me2-2,6).1b Whilst 5 reacts readily 
with CNtBu and CNC6H2Me3-2,4,6 at room temperature, 
liberating free PPh3, difficulties in purification precluded the 
isolation of the desired products, [Ru{BH(mt)2}(CO)(PPh3)(CNR)] 
(R = tBu, C6H2Me3-2,4,6). The infrared spectrum measured 
within two hours of the reaction between 5 and CNtBu in THF 
contained numerous overlapping peaks at 2109–2200 cm-1, as 
well as free CNtBu (2070 cm-1). The dominant bands at nCN = 
2134 and nCO = 1924 cm-1 may be evidence of the product of 
mono-substitution, [Ru{BH(mt)2}(CO)(PPh3)(CNtBu)]. Although 
a stoichiometric amount of CNC6H2Me3-2,4,6 was used in 
reaction with 5, incomplete reactivity was inferred by the 
presence of free CNC6H2Me3-2,4,6 (nCN = 2112 cm-1) in the IR 
spectrum after an extended period (43 hours). Despite the 
plethora of resonances (~11) in the 31P{1H} NMR spectrum, the 
IR spectrum following recrystallisation from THF/n-pentane 
showed evidence of the postulated product 
[Ru{BH(mt)2}(CO)(PPh3)(CNMes)] with stretching frequencies of 
nBH = 2360, nCN = 2088, and nCO = 1919 cm-1, in a mixture with 
an unidentified carbonyl containing complex at nCO = 1954 cm-1, 
a value inconsistent with zerovalent ruthenium. Neither 
fractional crystallisation nor column chromatography resulted 
in the isolation of a single pure material. 
Treatment of 5 with HC5Me6 (HCp*) was envisaged as a 
potential alternative route to Goh’s borate complex 
[Cp*Ru(CO){k2-S,S’-H2B(mt)2}],19h which is akin to 
[Cp*Ru(CO){k2-S,S’-H2B(azain)2}] (azain = 7-azaindolyl),34 
thereby concomitantly probing phosphine substitution and 
Ru®B reactivity.  No reaction occurred at room temperature, 
while raising the temperature to 80°C resulted in a mixture of 
products. These results perhaps unsurprisingly parallel those for 
HCºCPh and HBO2C6H4 discussed above in that the thermal 
conditions required for the Ru®B bond to participate directly 
in reactions appear incompatible with the endurance of the 
resulting products. This contrasts with the facile insertion of CS 
into a Rh®B bond leading to the unusual thioketone complex 
[RhH(PPh3){h2-C,S:k2-S’,S’’-SC(PPh3)BH(mt)2}].14 Treating 5 with 
CS2 might have been expected to afford the thiocarbonyl 
containing ruthenaboratrane [Ru(CS)(CO)(PPh3){BH(mt)2}], akin 
to [Ru(CS)(PPh3){B(mt)3}],1b however no reaction was observed 
at room temperature, despite the phosphine lability 
demonstrated above and the irreversible coordination of CS2 to 
other zerovalent ruthenium centres established elsewhere.35 At 
higher temperatures decomposition ensued with cleavage of 
the borane ligand and formation of free methimazole. 
 
Analysis and Comparison of Data 
The series of complexes of the form 
[Ru(CO)(L1)(L2){BH(mt)2}] synthesised from phosphine 
substitution reactions of 5 allow an appraisal of the effect of 
various co-ligands on the Ru®B bond, in addition to a 
comparison with the triptych derivatives, [Ru(CO)(L){B(mt)3}].1,8 
The key structural features of complexes 
[Ru(CO)(L1)(L2){BH(mt)2}] (5, 12, 14, 15 and 16) and 
[Ru(CO)(PPh3){B(mt)3}] (1a) are summarised in Table 1. 
Table 1. Selected Geometric and Spectroscopic Data for Diptych Ruthenaboratranes 
[Ru(CO)(L1)(L2){BH(mt) 2}] (L2 trans to Boron) 
L1 L2 Ru®B Ru–P(L1) Ru–P(L2) dB nCO 
  [Å] [Å] [Å] [ppm] [cm-1] 
PMe2Ph PMe2Ph 2.253(4) 2.288(1) 2.4094(8) 5.00 1877 
PMe2Ph PPh3 - - - 5.13 1890 
 PPh3 PPh3 2.246(2) 2.3044(4) 2.4766(4) 4.12 1893 
 Ph2PCH=CHPPh2 2.231(1) 2.2720(5) 2.3637(6) 5.05 1905 
P(OMe)3 P(OMe)3 2.252(3) 2.2340(9) 2.3604(9) 3.80 1921 
CO PPh3 2.237(2) – 2.4741(5) 2.97 1913, 1984 
mta PPh3 2.161(7) - 2.435(1) 17.1 1988  
a [Ru(CO)(PPh3){B(mt)3}].1,8 
The [Ru(CO)(L1)(L2){BH(mt)2}] series is ordered in Table 1 by 
increasing CO stretching frequency. This trend represents the 
relative decrease of electron density (p-basicity) of the 
ruthenium centres and parallels the progressive change of 
electronic properties of the phosphine ligands from s-basic 
PMe2Ph to p-acidic P(OMe)3. For the triptych analogues (nCO = 
1871 –1894 cm-1),8 this was shown to correlate well with 
Tolman’s [Ni(CO)3(L)]-derived electronic parameter36 and a 
similar trend is reproduced here and consistent with this 
observation, the nCO stretching frequency of 14 is some 44 cm-1 
lower than 15. Whilst retrodonation to carbonyl ligands involves 
metal orbitals of p-symmetry with respect to the M-L axes (‘t2g 
type’), retrodonation to boron involves a metal orbital of s-
symmetry (‘eg type’) such that variations in one will only 
indirectly perturb the other. There is no absolute correlation 
between Tolman’s electronic parameter and the Ru®B bond 
length, e.g., the two extremes of the series 14 (L1 = L2 = PMe2Ph) 
and 15 (L1 = L2 = P(OMe)3) have crystallographcally identical Ru-
B bond lengths (2.253(4) and 2.252(3) Å, respectively). It should 
also be noted that the Tolman cone angles for these two 
comparatively compact ligands are not so dissimilar (122 cf. 
107°). The shortest Ru®B bond length is observed for the 
dppen derivative 16 (2.231(1)Å) however that is perhaps to be 
expected given that the dppen chelate subtends an acute bite 
angle (85.29(2)°) whilst in all other cases the L1-Ru-L2 angle 
between donor atoms is obtuse. It must be stressed that for this 
series of similar complexes, the range of Ru®B bond lengths 
spans only some 22 pm whilst the precision for comparison of 
bond lengths (6 x e.s.d.) spans 6 – 24 pm, due in part to the 
caveats associated with locating comparatively light atoms such 
as boron, adjacent to heavy metal atoms, i.e., this geometric 
parameter is not likely to be reliably informative. Indirect 
insights into the impact of Ru®B bonding are, however, 
provided by the more precisely determined Ru–P bond lengths. 
In every case where two phosphines are present, the Ru–P bond 
length trans to the  Ru®B bond is very significantly longer than 
that trans to the thione, by as much as 0.058 Å in the case of 5. 
However, it should be noted that whilst 5 has the greatest 
disparity, this should not be attributed to the Ru-B trans 
influence alone, since of all the phosphines employed, PPh3 has 
the largest Tolman cone angle, i.e., there will be a steric as well 
as electronic component operating. The difference in bond 
lengths was found to be least pronounced for complex 16 with 
the bidentate dppen ligand, which may reflect the constraints 
of chelation over electronic considerations. Notably, no viable 
correlation could be inferred between the elongated Ru–L2 
bond and the Ru®B bond distance.  
Tricoordinate boranes are typically planar (S°BX3 » 360°), 
with pyramidalisation of the boron attending interaction with a 
metal (M®BX3; ideal tetrahedron (S°BX3 » 328°). Thus, the 
degree of pyramidalisation at the boron environment might be 
used to estimate the strength of the Ru®B bond.7c,37 
Notwithstanding the usual caveats associated with the precision 
of hydrogen atom positions in X-ray analysis, the angle sum 
S°BX3 values of the complexes in the [Ru(CO)(L1)(L2){BH(mt)2}] 
series span a comparatively narrow range of 317.5–326.1° 
bounded by 5 and 12 (Figure 10).  
 
Figure 10. Lack of relationship between the Ru®B distance and the pyramidalization 
sum around the boron (S°BX3) for complexes [Ru(CO)L2{BH(mt)2}] (blue) and 
[Ru(CO)L{B(mt)3}]8 (red) . 
A narrower range of 324.9–325.9° was established by the 
[Ru{B(mt)3}CO(L)] series. The geometry around boron deviates 
far from planarity in both series. This suggests a stronger M®B 
interaction than in Bourissou’s Group 9, 10 and 11 
metallaboratranes based on ambiphilic di- or tri- phosphino 
borane ligands adopting larger (i.e., more trigonal) S°BX3 values 
(e.g., Group 10, M®B: 341.8–336.7).7c,36 The variation of 
pyramidalisation is most remarkable between 5 and 12 where 
the smaller S°BX3 value (greater pyramidalisation) of the former 
may result from the greater steric imposition of PPh3 on the 
boron environment than CO. Indeed, whilst there is no obvious 
correlation between the degree of pyramidalization and 
associated Ru®B bond length (Figure 10), there is a monotonic 
relationship between pyramidalization and the Tolman steric 
parameter (qT, Figure 11), notwithstanding the uncertainties of 
defining such a parameter for CO (95°)36 and for chelating 
dppen, which we have approximated to PMePh2. This 
somewhat over-estimates the steric profile of each half of the 
dppen ligand given the constraints of chelation and the 
associated preclusion of free rotation around the metal-
phosphorus bond, an assumption upon which the Tolman 
parameter is based. Thus there is most likely even better 
correlation than might be suggested by the approximation to 
PMePh2.  Thus deformation of the boron coordination sphere, 
appears to be a plausible response to steric congestion that 
need not significantly compromise Ru®B binding. 
 
Figure 11. Correlation between the pyramidalization at boron and the Tolman steric 
parameter,35 qT, for the complexes [Ru(CO)L2{BH(mt)2}]. 
Conclusions 
The syntheses of diptych ruthenaboratranes have been 
developed, with the first example [Ru(CO)(PPh3)2{BH(mt)2}] (5) 
providing access to further examples via mono or disubstitution 
of the PPh3 ligands. Whilst extensive structural data attest to a 
significant trans influence on the part of the Ru®B bond, the 
trans effect is somewhat more subtle in that the kinetic 
products of monosubstitution (12,13) have the extraneous 
ligand positioned cis to the Ru®B bond. We attribute this to the 
geometric flexibility of the 5-coordinate intermediate arising 
from initial PPh3 dissociation, with rearrangement to present 
the vacant coordination site in the cis position rather than trans 
to the Ru®B bond. Implicit in this interpretation is the 
reluctance of CO to assume the position trans to the Ru-B bond 
rather than the more s-basic phosphorus ligands, which would 
also tally with the lability of the CO ligand observed in the 
triptych system for [Ru(CO)2{B(mt)3}].1b We are unable at this 
stage to discount arrival at the thermodynamic isomer via an 
initially formed kinetic isomer that undergoes a subsequent 
non-dissociative isomerism such as the Ray-Dutt or Bailar twist 
mechanisms.38 We have previously observed such a process to 
occur upon heating octahedral cationic triptych 
rhodaboratranes22 and Ball and Mann have provided NMR-
derived evidence for [RuH2(CO)(PPh3)3] undergoing 
intramolecular phosphine site exchange upon heating.37d Given 
the mild conditions employed herein, we remain disposed 
towards the 5-coordinate pseudo-rotation interpretation.  It 
should however be noted in this context that 5-coordinate 
rhodaboratranes have been isolated in which the ground state 
has the contrary geometry with a vacant site trans to the Rh®B 
bond, e.g., Bourissou’s 2-phosphinoaryl borane archetype 
[RhCl(DMAP){BPh(C6H4PiPr2-2)2}],7a the preference for reduced 
coordination numbers for group 9 (cf. group 8) notwithstanding. 
 
Scheme 6. Regioselectivity of ligand substitution in diptych ruthenaboratranes. 
The peculiarities of the coordination chemistry of Z-type 
(i.e., s-Lewis acidic) ligands39 in contrast to more classical 
electron-pair donor ligands (X, L) would seem to call for further 
study. 
Experimental 
General Consideration - All manipulations were carried out 
under a dry and oxygen-free nitrogen atmosphere using 
standard Schlenk vacuum line, and inert atmosphere dry-box 
techniques, with dried and degassed solvents that were distilled 
from either calcium hydride (CH2Cl2) or sodium and 
benzophenone (ethers, hexane, THF, toluene, xylene and 
paraffins). NMR spectra were obtained at 298 K on a Varian 
Mercury 300 (1H: 300.1 MHz, 31P: 121.5 MHz), a MR 400 (1H: 
399.8 MHz, 31P: 161.8 MHz), a Bruker Avance 400 (1H: 400.1 
MHz, 11B: 128.4 MHz, 13C: 100.6 MHz, 31P: 162.0 MHz), a Bruker 
Avance 600 (1H: 600.0 MHz, 13C: 150.9 MHz), or a Bruker Avance 
700 (1H: 700.2 MHz, 13C: 176.1 MHz, 31P: 283.5 MHz). 1H 
chemical shift (d) data were referenced to residual solvent 
peaks in deuterated solvent. 13C chemical shift (d) data were 
referenced to the resonances of the deuterated solvent. 31P and 
11B were referenced to external 85% H3PO4 or BF3.OEt2 
standards, respectively. Infrared spectra were obtained with a 
Bruker Alpha FTIR with diamond plate Attenuated Total 
Reflectance sampling attachment, run at 4 cm-1 resolution. 
Solution infrared spectra were obtained using a Perkin-Elmer 
Spectrum One FT-IR Spectrometer. Elemental microanalysis was 
performed by the London Metropolitan University. Electrospray 
(ESI) mass spectrometry were performed by the Research 
School of Chemistry mass spectrometry service. Data for X-ray 
crystallography were collected with an Agilent SupaNova 
diffractometer. The complexes [RuCl(Ph)(CO)(PPh3)2]15 and 
[RuCl(CH=CHPh)(CO)(PPh3)2]16 and the pro-ligand salt 
Na[H2B(mt)2]17 were prepared as described previously. Other 
reagents were used as received from commercial suppliers. 
 
Synthesis of [Ru(CO)(PPh3)2{BH(mt)2}](Ru®B)8 (5). Method 
1: A suspension of [RuCl(Ph)(CO)(PPh3)2] (0.500 g, 0.65 mmol) 
and Na[H2B(mt)2] (0.175, 0.67 mmol) in diethyl ether (50 mL) 
was stirred for 15 h, by which time the suspension had lightened 
from an orange colour to beige. The solvent was removed in 
vacuo and the resulting residue was re-dissolved in 
dichloromethane (30 mL). The filtrate was transferred to 
another Schlenk flask by cannula filtration. An equal volume of 
ethanol was added, and the solvent was removed slowly under 
reduced pressure to afford a beige precipitate that was filtered 
and dried under high vacuum. Yield: 0.198 g (0.222 mmol, 34%). 
Method 2: A suspension of [RuHCl(CO)(PPh3)3] (1.000 g, 1.05 
mmol) and ethynylbenzene (0.30 mL, 2.7 mmol, excess) in 
dichloromethane (35 mL) was stirred for 1.5 h, by which time 
the solution had turned to a deep red colour at which point 
Na[H2B(mt)2] (0.275 g, 1.05 mmol) was added. The reaction 
mixture was stirred for a further 18 h, and the filtrate isolated 
by cannula filtration. The solvent was concentrated in vacuo to 
≈ 5 mL. Diethyl ether (20 mL) was added to the yellow oily 
residue, to afford a pale yellow solid that was isolated by 
cannula filtration. Petroleum ether was added and the solid 
collected on a sintered funnel, washed with diethyl ether and 
petroleum ether, then dried under high vacuum. Yield: 0.570 g 
(0.639 mmol, 61%). Crystals of a diethyl ether solvate suitable 
for crystallographic analysis were obtained from slow 
evaporation of a concentrated solution of 5 in diethyl ether over 
one day. IR (ATR, cm-1): 2316 nBH, 1893 nCO. IR (CH2Cl2): 2397 nBH, 
1899 nCO. 1H NMR (400 MHz, CDCl3): dH = 3.07, 3.33 (s x 2, 3 H x 
2, CH3), 4.07 (s, v.br., 1 H, BH), 6.04 (d, 1 H,  
3JHH = 1.8, NCH=CH), 6.15 (d, 1 H, 3JHH = 1.8, NCH=CH), 6.50 (d, 
1H, 3JHH = 1.7, NCH=CH), 6.58 (d, 1 H, 3JHH = 1.8, NCH=CH), 6.97 –
7.07 (m, 9 H, C6H5), 7.22 – 7.26 (m, 9 H, C6H5),  
7.40 – 7.47 (m, 12 H, C6H5). 13C{1H} NMR (176 MHz, CDCl3): dC = 
33.7, 34.1 (CH3 x 2), 119.8 (NCH=CH), 120.3 (NCH=CH), 120.7 
(NCH=CH), 120.9 (NCH=CH), 126.4 [d, 2,3JCP = 8.8, C2,3,5,6(C6H5)], 
127.5 [br, C2,3,5,6(C6H5) for PPh3 trans to B), 128.1 [d, 4JCP = 1.8, 
C4(C6H5)], 128.5 [C4(C6H5) for PPh3 trans to B), 134.3 [d, 2,3JCP = 
14.1, C2,3,5,6(C6H5) for PPh3 trans to B), 134.5 (d,  
2,3JCP = 8.8, C2,3,5,6(C6H5)], 137.1 [d, 1JCP = 19.4, C1(C6H5) for PPh3 
trans to B), 137.9 [d, 1JCP = 40.5, C1(C6H5)], 163.6, 164.8 (CS x 2), 
208.5 (d, 2JCP = 15.6, CO). 31P{1H} NMR (162 MHz, CDCl3): dP = 
52.7 (s.br., PPh3 trans to S), 19.3 (s.br., PPh3 trans to B, 2JPP not 
resolved). 11B{1H} NMR (128 MHz, CDCl3): dB = 4.12 (s.br.). 11B 
NMR (128 MHz, CDCl3): dB = 3.81 (s.br., 1JBH not resolved). ESI-
MS(+) m/z = 895.2 [M–CO+OMe]+. Accurate mass: Found 
895.1592 [M–CO+OMe]+, Calcd. for C45H4411BN4OP2102RuS2: 
895.1568. Anal. Found: C, 60.52; H, 4.77; N, 6.13%. Calcd. for 
C45H41BN4OP2RuS2: C, 60.61; H, 4.63; N, 6.28%. Crystal data for 
C45H41BN4OP2RuS2.C4H10O at 185 K: Mw = 965.93, monoclinic, 
P21/n, a = 12.2007(3) Å, b = 24.2676(5) Å, c = 15.8232(3) Å, b = 
99.4773(19) °, V = 4621.02(9) Å3, Z = 4, Dcalcd = 1.388 Mg m-3, 
µ(Mo Ka) = 0.54 mm-1, T = 185(2) K, clear pale yellow block, 0.14 
x 0.10 x 0.06 mm, 10,695 independent reflections. F2 
refinement, R1 = 0.037, wR2 = 0.070 for 8,455 reflections (I > 
2.0s(I), 2qmax = 60°), 553 parameters, 0 restraints. Crystal data 
for C45H41BN4OP2RuS2.C4H10O: Mw = 965.93, monoclinic, P21/n, 
a = 12.2141(1) Å, b = 24.2890(2) Å, c = 15.8351(1) Å, b = 
99.4996(7)°, V = 4633.35 (3) Å3, Z = 4, Dcalcd = 1.385 Mg m-3, µ(Cu 
Ka) = 4.57 mm-1, T = 150(2) K, clear pale yellow block, 0.12 x 
0.08 x 0.08 mm, 9,370 independent reflections. F2 refinement, 
R1 = 0.023, wR2 = 0.058 for 9,370 reflections (I > 2.0s(I), 2qmax = 
144°), 553 parameters, 0 restraints CCDC1881115. Crystal data 
for [Ru(Ph)(k2-N,S-mt)(CO)(PPh3)2] (6), see also Reference 21. 
C47H40N2OP2RuS: Mw = 843.93, monoclinic, P21/n, a = 13.1748(1) 
Å, b = 18.1695(1) Å, c = 17.5732(1) Å, b = 110.7668(8)°, V = 
3933.36(2) Å3, Z = 4, Dcalcd = 1.425 Mg m-3, µ(Cu Ka) = 4.79 mm-
1, T = 150(2) K, clear light yellow needle, 0.22 x 0.05 x 0.04 mm, 
7,972 independent reflections. F2 refinement, R1 = 0.024, wR2 = 
0.062 for 7,260 reflections (I > 2.0s(I), 2qmax = 60°), 487 
parameters, 0 restraints. Crystal data for 
[Ru(C≡CPh)(CO)(PPh3){H2B(mt)2}] (8) C35H32BN4OPRuS2-CHCl3: 
Mw = 850.98, triclinic, P-1 (No. 2), a = 9.9810(7) Å, b = 11.0018(6) 
Å, c = 19.3279(8) Å, a = 73.725(4)°, b = 82.147(4)°, g = 
65.670(6)°, V = 1855.8(2) Å3, Z = 2, Dcalcd = 1.523 Mg m-3, µ(Cu 
Ka) = 7.15 mm-1, T = 150(2) K, yellow prism, 0.11 x 0.08 x 0.04 
mm, 7,474 independent reflections. F2 refinement, R1 = 0.032, 
wR2 = 0.083 for 6,775 reflections (I > 2.0s(I), 2qmax = 144°), 450 
parameters, 0 restraints, CCDC 1881116. 
 
Reaction of [Ru(CO)(PPh3)2{BH(mt)2}] with HCl. An ethereal 
solution of hydrogen chloride (0.25 mL, 1M, 0.25 mmol) was 
added to a stirred solution of [Ru(CO)(PPh3)2{BH(mt)2}] (5: 0.200 
g, 0.22 mmol) in tetrahydrofuran and the mixture was stirred 
for 24 h. The 31P{1H} NMR spectrum revealed a mixture of 
products at dP = 55.2, 50.0, 45.2, 35.7, 28.1 and 19.1 in addition 
to free triphenylphosphine. The solvent was removed using a 
rotary evaporator and the orange residue was crystallized from 
chloroform and n-pentane. The crystals were collected on a 
sintered frit and dried in air to give a mixture of the products 
below. Combined yield: 0.073 g.  
Product 1: [RuCl2(CO)(PPh3)2(Hmt)] (9): ESI-MS(+) m/z: 803.1 
[M–Cl]+, 844.1 [M–Cl + MeCN]+. Accurate mass: Found 803.0754 
[M–Cl]+, Calcd. for C41H36N2O35Cl2P2S102Ru: 803.0750; Found 
844.1021 [M–Cl+MeCN]+, Calcd. for C43H39N3O35ClP2S102Ru: 
844.1016. Crystal data for C41H36Cl2N2OP2RuS.CHCl3: Mw = 
958.11, monoclinic, P21/c, a = 11.5279(1), b = 20.9802(1), c = 
18.3591(2) Å, V = 4222.02(5) Å3, Z = 4, Dcalcd = 1.507 Mg m-3, µ(Cu 
Ka) = 7.38 mm-1, T = 150(2) K, orange needle, 0.18 x 0.05 x 0.05 
mm, 8,525 independent reflections. F2 refinement, R1 = 0.031, 
wR2 = 0.078 for 7,799 reflections (I > 2.0s(I), 2qmax = 144°), 490 
parameters, 0 restraints, CCDC 1881118. 
Product 2: [RuCl2(CO)(PPh3)(Hmt)2] (10): Washing the isolated 
mixture with chloroform and filtering under vacuum suction 
afforded a second product. IR (ATR, cm-1): 3028 nCH, 1961 nCO. 
1H NMR (400 MHz, CDCl3): dH = 3.42 (s, 6 H, CH3), 6.61 (t, 2 H, 
3JHH = 2.3, NCH=CH), 6.75 (t, 2 H, 3JHH = 2.4, NCH=CH), 7.30 – 7.33 
(m, 9 H, C6H5), 7.79 – 7.82 (m, 6 H, C6H5), 12.92 (s.br., 2 H, NH). 
13C{1H} NMR (100 MHz, CDCl3): dC = 34.2 (CH3), 115.2 (NCH=CH), 
119.5 (NCH=CH), 127.6 [d, 2,3JCP = 10.0, C2,3,5,6(C6H5)], 129.7 [d, 
4JCP = 3.0, C4(C6H5)], 133.8 [d, 1JCP = 48.3, C1(C6H5)], 134.5 [d, 2,3JCP 
= 9.1, C2,3,5,6(C6H5)], 158.1 (CS). 31P{1H} NMR (162 MHz, CDCl3): 
dP = 45.1. ESI-MS(+) m/z: 689.1 [M–H]+, 655.0 [M–Cl]+. Accurate 
mass: Found 655.0102 [M–Cl]+, Calcd. for 
C27H27N4O35ClPS2102Ru: 655.0104. Crystal data for 
C27H27Cl2N4OPRuS2: Mw = 690.58, monoclinic, Cc, a = 9.2352(4),  
b = 16.5996(6), c = 18.7713(7) Å, b = 94.733(4)°, V = 2867.84(19) 
Å3, Z = 4, Dcalcd = 1.599 Mg m-3, µ(Mo Ka) = 0.96 mm-1, T = 150(2) 
K, yellow block, 0.18 x 0.12 x 0.06 mm, 5,442 independent 
reflections. F2 refinement, R1 = 0.029, wR2 = 0.065 for 5,212 
reflections (I > 2.0s(I), 2qmax = 144°), 345 parameters, 2 
restraints, CCDC 1881117.  
 
Synthesis of [Ru{BH(mt)2}(CO)2(PPh3)] (Ru®B)8 (12). 
Carbon monoxide (1 atm) was bubbled through a stirred 
solution of [Ru(CO)(PPh3)2{BH(mt)2}] (5: 0.205 g,  
0.23 mmol) in dichloromethane for 15 min. The solvent was 
removed in vacuo to give a yellow residue, which was then 
suspended in diethyl ether (10 mL). The yellow solid was 
isolated by cannula filtration, washed with n-pentane (20 mL) 
and dried under vacuum. Yield: 0.079 g (0.120 mmol, 52%). 
Crystals of a chloroform solvate 12.CHCl3 suitable for 
crystallographic analysis were obtained from slow evaporation 
of a concentrated solution of 12 in chloroform/n-pentane over 
one day. IR (ATR, cm-1): 2344 nBH, 1984, 1913 nCO. 1H NMR (700 
MHz, CDCl3): dH = 3.43 (s, 6 H, CH3), 6.62 (s, 2 H, NCH=CH), 6.69 
(s, 2 H, NCH=CH), 7.36 – 7.39 (m, 9 H, C6H5), 7.52 – 7.55 (m, 6H, 
C6H5). 13C{1H} NMR (176 MHz, CDCl3): dC = 34.4 (CH3), 120.9 
(NCH=CH), 122.1 (NCH=CH), 128.3 [d, 2,3JCP = 8.8, C2,3,5,6(C6H5)], 
129.4 [d, 4JCP = 1.2, C4(C6H5)], 133.6 [d, 2,3JCP = 13.2, C2,3,5,6(C6H5), 
136.3 [d, 1JCP = 27.1, C1(C6H5), 163.9 (d, 3JCP = 20.2, CS), 202.9 (d, 
2JCP = 2.4, CO). 31P{1H} NMR (162 MHz, CDCl3): dP = 20.1. 11B NMR 
(128 MHz, CDCl3): dB = 2.97 (s.br.). ESI-MS(+) m/z: 648.1 [M–B]+, 
659.0 [M+H]+. Accurate mass: Found 659.0441 [M+H]+, Calcd. 
for C28H2711BN4O2PS2102Ru: 659.0450. Anal. Found: C, 51.29; H, 
3.95; N, 8.37%. Calcd. for C28H26BN4O2PRuS2: C, 51.15; H, 3.99; 
N, 8.52%. Crystal data for C28H26BN4O2PRuS2.CHCl3: Mw = 
776.90, monoclinic, P21/c, a = 9.7228(1), b = 18.6012(1), c = 
17.8876(1) Å, V = 3205.42(2) Å3, Z = 4, Dcalcd = 1.610 Mg m-3, µ(Cu 
Ka) = 8.24 mm-1, T = 150(2) K, yellow trapezoid, 0.31 x 0.25 x 
0.16 mm, 6,486 independent reflections. F2 refinement, R1 = 
0.029, wR2 = 0.078 for 7,799 reflections (I > 2.0s(I),  
2qmax = 144°), 391 parameters, 0 restraints, CCDC 1881122. 
 
Synthesis of [Ru(CO)(PMe2Ph)(PPh3){BH(mt)2}] (Ru®B)8 
(13). A solution of [Ru(CO)(PPh3)2{BH(mt)2}] (5: 0.203 g, 0.23 
mmol) and PMe2Ph (0.10 mL, 0.70 mmol) in tetrahydrofuran (20 
mL) was stirred for 4 h. The solvent was removed in vacuo to 
give an oily orange residue. Diethyl ether (20 mL) was added to 
afford a pale yellow solid that was isolated by cannula filtration. 
The solid was suspended in n-pentane and collected on a sinter 
funnel, washed with n-pentane, then dried under high vacuum. 
Yield: 0.059 g (0.077 mmol, 34%). IR (ATR, cm-1): 3044 nCH, 2363 
nBH, 1890 nCO. IR (THF, cm-1): 2337 nBH, 1902 nCO. 1H NMR (400 
MHz, CDCl3): dH = 1.28 (d, 3 H, 2JHP = 5.5, PCH3), 1.43 (d, 3 H, 2JHP 
= 5.3, PCH3), 3.00 (s, 3 H, NCH3), 3.43 (s, 3 H, NCH3), 6.19 (d, 2 H,  
3JHH = 2.6, NCH=CH), 6.60 (s, 2 H, NCH=CH), 7.07 – 7.13 (m, 9 H, 
C6H5), 7.30 – 7.52 (m, 14 H, C6H5). Decomposition in CDCl3 
confounded the acquirement of useful 13C{1H} NMR data. 
31P{1H} NMR (162 MHz, CDCl3): dP = 56.9 (d,  
1JPC = 11.3, PPh3), –17.2 (s.br., PMe2Ph). 11B{1H} NMR (128 MHz, 
CDCl3): dB = 5.13 (s.br.). 1H NMR (400 MHz, CD2Cl2): dH = 1.25 (d, 
3 H, 2JHP = 5.5, PCH3), 1.38 (d, 3 H, 2JHP = 5.3, PCH3), 2.97 (s, 3 H, 
NCH3), 3.49 (s, 3 H, NCH3), 6.19 (d, 1 H, 3JHH = 1.4, NCH=CH), 6.27 
(s, 1 H, NCH=CH), 6.63 (d, 1 H, 3JHH = 1.5, NCH=CH), 6.67 (s, 1 H, 
NCH=CH), 7.07 – 7.16 (m, 9 H, C6H5), 7.31 – 7.48 (m, 14 H, C6H5). 
31P{1H} NMR (162 MHz, CD2Cl2): dP = 56.2 (s.br., PMe2Ph), –17.7 
(s.br., PPh3). ESI-MS(+) m/z: 769.1 [M+H]+. Accurate mass: 
Found 769.1099 [M+H]+, Calcd. for C35H38ON411BP2S2102Ru 
769.1093. Anal. Found: C, 55.29; H, 5.02; N, 7.13%. Calcd. for 
C35H37BN4OP2RuS2: C, 54.76; H, 4.86; N, 7.30%. 
 
Synthesis of [Ru(CO)(PMe2Ph)2{BH(mt)2}] (Ru®B)8 (14). A 
solution of [Ru(CO)(PPh3)2{BH(mt)2}] (5: 0.200 g, 0.22 mmol) 
and PMe2Ph (0.30 mL, 2.7 mmol) in tetrahydrofuran (20 mL) was 
heated under reflux for 18 h. The solvent was reduced to 3 mL 
and diethyl ether (10 mL) and n-pentane (15 mL) were added to 
afford a pale yellow solid that was isolated by cannula filtration 
and dried under high vacuum. Yield: 0.079 g (0.12 mmol, 55%). 
Crystals suitable for crystallographic analysis were obtained 
from slow evaporation of a concentrated solution of 14 in 
tetrahydrofuran/diethyl ether/n-pentane over one day. IR (ATR, 
cm-1): 2298 nBH, 1877 nCO. IR (THF, cm-1): 2323 nBH, 1902 nCO. 1H 
NMR (700 MHz, CDCl3): dH = 1.27 (d, 3 H, 2JHP = 8.6, PCH3), 1.38 
(d, 3 H, 2JHP = 5.0, PCH3), 1.43 (d, 3 H, 2JHP = 5.4, PCH3), 1.48 (d, 3 
H, 2JHP = 8.4, PCH3), 3.40 (s, 3 H, NCH3), 3.44 (s, 3 H, NCH3), 6.48 
(d, 1 H, 3JHH = 1.6, NCH=CH), 6.53 (s, 1 H, NCH=CH), 6.58 (s, 1 H, 
NCH=CH), 6.65 (d, 1 H, 3JHH = 1.7, NCH=CH), 7.09 – 7.13 (m, 3 H, 
C6H5), 7.20 – 7.22 (m, 2 H, C6H5), 7.26 – 7.28 (m, 1 H, C6H5), 7.31 
– 7.33 (m, 2 H, C6H5), 7.43 – 7.46 (m, 2 H, C6H5). 13C{1H} NMR 
(176 MHz, CDCl3): dC = 15.6 (dd, 1JCP = 31.2, 3JCP = 3.3, PCH3), 16.3 
(d, 1JCP = 13.6, PCH3), 18.6 (dd, 1JCP = 32.3, 3JCP = 4.2, PCH3), 19.4 
(d, 1JCP = 16.2, PCH3), 34.1 (NCH3), 34.1 (NCH3), 120.6 (d, 4JCP = 
8.4, NCH=CH) overlapping with 120.6 (d, 4JCP = 7.6, NCH=CH), 
121.1 (NCH=CH), 121.5 (NCH=CH), 127.3 [d, 2,3JCP = 8.2, 
C2,3,5,6(C6H5), 128.0 [d, 2,3JCP = 7.7, C2,3,5,6(C6H5), 127.6 [C4(C6H5)], 
127.8 [C4(C6H5)], 129.3 [d, 2,3JCP = 7.8, C2,3,5,6(C6H5), 129.7 [d, 2,3JCP 
= 11.4, C2,3,5,6(C6H5), 143.2 [dd, 1JCP = 35.1, 3JCP = 5.9, C1(C6H5), 
143.3 [d, 1JCP = 20.7, C1(C6H5)], 165.0 (d, 3JCP = 23.7, CS), 165.3 
(d, 3JCP = 20.2, CS), 207.7 (dd, 2JCP = 15.5, 2JCP = 3.3, CO). 31P NMR 
(283 MHz, CDCl3): dP = 14.5 (m.br., coupling not resolved, 
PMe2Ph trans to S), –16.4 (s.br., PMe2Ph trans to B). 31P{1H} 
NMR (283 MHz, CDCl3): dP = 14.5 (d, 1JPC = 12.3, PMe2Ph trans to 
S), –16.4 (s.br., PMe2Ph trans to B). 11B NMR (128 MHz, CDCl3): 
dB = 5.00 (s.br.). ESI-MS(+) m/z: 633.0 [M – B]+. Accurate mass: 
Found 1311.1317 [2M + Na]+, Calcd. for 
C50H6611B2N8O223NaP4S4102Ru2: 1311.1313. Anal. Found: C, 
46.57; H, 5.28; N, 8.63%. Calcd. for C25H33BN4OP2RuS2: C, 46.66; 
H, 5.17; N, 8.71%. Crystal data for C25H33BN4OP2RuS2: Mw = 
643.52, orthorhombic, Pbca, a = 8.5565(1), b = 18.5822(2), c = 
36.1544(3) Å, V = 5748.50(5) Å3, Z = 8, Dcalcd = 1.487 Mg m-3, µ(Cu 
Ka) = 7.03 mm-1, T = 150(2) K, clear colourless block, 0.19 x 0.10 
x 0.05 mm, 5,806 independent reflections. F2 refinement, R1 = 
0.039, wR2 = 0.098 for 5,659 reflections (I > 2.0s(I), 2qmax = 
144°), 328 parameters, 0 restraints, CCDC 1881123. 
 
Synthesis of [Ru(CO){P(OMe)3}2{BH(mt)2}] (Ru®B)8   (15). 
A solution of [Ru(CO)(PPh3)2{BH(mt)2}] (5: 0.202 g, 0.22 mmol) 
and P(OMe)3 (0.10 mL, 0.85 mmol) in tetrahydrofuran (20 mL) 
was stirred for 18 h. The solvent was removed in vacuo and 
diethyl ether (10 mL) and n-pentane (15 mL) were added to 
afford a pale yellow solid that was isolated by cannula filtration 
and dried under high vacuum. Yield: 0.041 g (0.067 mmol, 30%). 
Crystals suitable for crystallographic analysis were obtained 
from slow evaporation of a concentrated solution of 15 in 
chloroform/n-pentane over one day. IR (ATR, cm-1): 2358 nBH,  
1921 nCO. IR (THF, cm-1): 2244 nBH, 1934 nCO. 1H NMR (700 MHz, 
CDCl3): dH = 3.49 (s, 3 H, NCH3), 3.49 (s, 3 H, NCH3), 3.56 (d, 9 H, 
3JHP = 10.8, OCH3), 3.67 (d, 9 H, 3JHP = 11.1, OCH3), 6.62 (d, 2 H, 
4JHP = 6.6, NCH=CH), 6.69 (dd, 2 H, 4JHP = 8.1, 3JHH = 1.8, NCH=CH). 
13C{1H} NMR (176 MHz, CDCl3): dC = 34.2 (NCH3), 34.3 (NCH3), 
50.8 (br., P trans to B), 52.0 (d, 2JCP = 5.9, P trans to S), 120.9 (d, 
4JCP = 4.2, NCH=CH), 121.0 (d, 4JCP = 4.1, NCH=CH), 121.5 (d, 4JCP 
= 1.2, NCH=CH), 121.6 (NCH=CH), 165.3 (d, 3JCP = 24.3, CS), 166.9 
(d, 3JCP = 28.4, CS), 207.7 (dd, 2JCP = 18.8, 2JCP = 5.5, CO).  
31P{1H} NMR (162 MHz, CDCl3): dP = 151.1 (d, 2JPP = 19.4, P trans 
to S), 153.7 (s.br., P trans to B). 31P NMR (162 MHz, CDCl3): dP = 
151.1 (m, 2JPP = 10.5, P trans to S), 153.7 (s.br., P trans to B). 11B 
NMR (128 MHz, CDCl3): dB = 3.62 (s.br.).  11B{1H} NMR (128 MHz, 
CDCl3): dB = 3.80 (s.br.). ESI-MS(+) m/z: 617.0 [M+H]+. Accurate 
mass: Found 617.0166 [M+H]+, Calcd. For 
C15H2911BN4O7P2S2102Ru: 617.0162. Anal. Found: C, 29.35; H, 
4.71; N, 8.98%. Calcd. for C15H29BN4O7P2RuS2: C, 29.28; H, 4.75;  
N, 9.10%. Crystal data for (C15H29BN4O7P2RuS2)3: Mw = 1846.13, 
triclinic, P-1 (No.2), a = 9.4439(1), b = 15.2581(3), c = 26.4419(4) 
Å, a = 93.1670(14)°, b = 92.0931(12)°, g = 93.9263(13)°, V = 
3792.32(6) Å3, Z = 2, Dcalcd = 1.617 Mg m-3, µ(Cu Ka) = 8.14 mm-
1, T = 150(2) K, colourless needles, 0.42 x 0.06 x 0.04 mm, 15,286 
independent reflections. F2 refinement, R1 = 0.038, wR2 = 0.098 
for 13,859 reflections (I > 2.0s(I), 2qmax = 144°), 914 parameters, 
0 restraints, CCDC 1881124. 
 
Synthesis of [Ru(CO)(Z-Ph2PCH=CHPPh2){BH(mt)2}] 
(Ru®B)8 (16). A solution of [Ru(CO)(PPh3)2{BH(mt)2}] (5: 0.200 
g, 0.22 mmol) and Z-PPh2CH=CHPPh2 (0.090 g, 0.22 mmol) in 
tetrahydrofuran (20 mL) was heated under reflux for 43 h. The 
solvent was removed in vacuo and diethyl ether was added to 
the orange residue to give a yellow solid that was isolated by 
cannula filtration. The solid was redissolved in tetrahydrofuran 
and layered with n-pentane. The filtrate was decanted to afford 
a yellow precipitate that was dried in air. Yield: 0.042 g (0.055 
mmol, 24%). Crystals suitable for crystallographic analysis were 
obtained from vapour diffusion of n-pentane into a 
concentrated solution of 16 in acetone over one day. IR (ATR, 
cm-1): 2354 νBH, 1905 νCO cm-1. IR (THF): 2338 nBH, 1923 nCO. 1H 
NMR (700 MHz, CDCl3): dH = 2.68 (s, 3 H, NCH3), 3.55 (s, 3 H, 
NCH3), 6.15 (s, 1 H, NCH=CH), 6.51 (s, 1 H, NCH=CH), 6.66 (s, 1 
H, NCH=CH), 6.73 (s, 1 H, NCH=CH), 6.97 (m.br., 3 H, C6H5), 7.04 
– 7.07  (m, 2 H, C6H5), 7.22 – 7.24 (m, 1 H, C6H5), 7.28 – 7.47 (m, 
9 H, C6H5), 7.71 – 7.79 (m, 3 H, C6H5), 7.90 – 7.92 (m, 1 H, 
PCH=CHP), 7.97 – 7.99 (m, 1 H, PCH=CHP), 8.04 – 8.06 (m, 2 H, 
C6H5). 13C{1H} NMR (151 MHz, CDCl3): dC = 33.3 (NCH3), 34.3 
(NCH3), 120.4 (NCH=CH) overlapping with 120.5 (d, 4JCP = 3.0, 
NCH=CH), 120.8 (d, 4JCP = 3.0, NCH=CH), 121.7 (NCH=CH), 125.7 
[d, 2,3JCP = 9.6, C2,3,5,6(C6H5), 127.4 [C4(C6H5)], 128.0 [d,  
2,3JCP = 9.4, C2,3,5,6(C6H5)], 128.4 [d, 2,3JCP = 8.8, C2,3,5,6(C6H5)], 
128.5 [d, 2,3JCP = 8.4, C2,3,5,6(C6H5)], 128.7 [C4(C6H5)], 129.4 
[C4(C6H5)], 129.6 [C4(C6H5)], 131.1 [d, 2,3JCP = 8.5, C2,3,5,6(C6H5)], 
131.6 [d, 2,3JCP = 13.2, C2,3,5,6(C6H5)], 133.0 [d, 2,3JCP = 14.6, 
C2,3,5,6(C6H5), 133.4 [d, 2,3JCP = 9.8, C2,3,5,6(C6H5), 135.5 [dd,  
1JCP = 44.1, 3JCP = 4.5, C1(C6H5)], 137.0 [d, 1JCP = 9.1, C1(C6H5)], 
137.2 [d, 1JCP = 16.2, C1(C6H5), 139.5 [d, 1JCP = 27.2, C1(C6H5), 
148.1 [dd, 1JCP = 26.6, 2JCP = 26.6, PCH=CHP), 149.0 (dd, 1JCP = 
35.8, 2JCP = 45.5, PCH=CHP), 164.5 (d, 3JCP = 22.7, CS), 166.1 (d, 
3JCP = 19.6, 3JCP = 1.5, CS), 206.9 (d, 2JCP = 10.6, CO). 31P{1H} NMR 
(162 MHz, CDCl3): dP = 70.6 (d, 2JPP = 8.1, P trans to S), 50.8 (s.br., 
P trans to B). 11B NMR (128 MHz, CDCl3): dB = 5.05 (s.br.). ESI-
MS(+) m/z: 765.1 [M+H]+. Accurate mass: Found 765.0785 
[M+H]+, Calcd. for C35H3411BN4OP2S2102Ru 765.0780. Anal. 
Found: C, 54.97; H, 4.30; N, 7.22%. Calcd. for C35H33BN4OP2RuS2: 
C, 55.05; H, 4.36; N, 7.34%. Crystal data for C35H33BN4OP2RuS2: 
Mw = 763.63, triclinic, P-1 (No.2), a = 10.4568(5),  
b = 12.4325(5), c = 15.9030(7) Å, a = 68.191(4)°, b = 82.434(4)°, 
g = 71.916(4)°, V = 1824.35(8) Å3, Z = 2, Dcalcd = 1.390 Mg m-3, 
µ(Cu Ka) = 5.64 mm-1, T = 150(2) K, yellow block, 0.21 x 0.14 x 
0.07 mm, 7,333 independent reflections. F2 refinement, R1 = 
0.037, wR2 = 0.101 for 6,926 reflections (I > 2.0s(I), 2qmax = 
144°), 418 parameters, 0 restraints, CCDC 1881125. 
Attempted synthesis of [Ru{k3-B,S,S’-
B(mt)2}(CO)(PPh3)2]PF6; Observation of 
[RuF(Hmt)2(CO)(PPh3)2]PF6 [11]PF6. A solution of 
[Ru(CO)(PPh3)2{BH(mt)2}] (5: 0.100 g, 0.112 mmol) and 
[CPh3]PF6 (0.037 g, 0.095 mmol) in tetrahydrofuran (10 mL) was 
stirred for 24 h. The solvent was removed in vacuo and diethyl 
ether (10 mL) was added to afford an orange precipitate that 
was isolated via cannula filtration. Crude mixture: IR (THF, cm-
1): 1931 nCO, 1972 nCO. 31P{1H} NMR  
(162 MHz, C6D6): dP = 39.6 (s.br.), ‒142.9 (h, 1JPF = 713.9, PF6), ‒
5.3 (s.br., PPh3). The orange precipitate had poor solubility in 
C6D6. 31P{1H} NMR (162 MHz, CDCl3): dP = 43.8, 39.0 (s.br.), 35.3, 
26.2, 24.9, ‒144.3 (h, 1JPF = 714.7, PF6), ‒5.3 (PPh3). Crystals of 
[RuF(Hmt)2(CO)(PPh3)2]PF6 [11]PF6 suitable for crystallographic 
analysis were obtained from slow evaporation of a 
concentrated solution of the crude reaction mixture in 
benzene/n-pentane over one day. Crystal data for 
C45H42FN4OP2RuS2.F6P.C6H6: Mw = 1124.03, monoclinic, P21/c, a 
= 14.5664(1), b = 15.1058(1), c = 23.6542(2) Å, V = 5016.47(7) 
Å3, Z = 4, Dcalcd = 1.488 Mg m-3, µ(Cu Ka) = 4.80 mm-1, T = 150(2) 
K, yellow block, 0.18 x 0.11 x 0.07 mm, 10,144 independent 
reflections. F2 refinement, R1 = 0.044, wR2 = 0.104 for 9,278 
reflections (I > 2.0s(I), 2qmax = 144°), 729 parameters, 96 
restraints, CCDC 1881121. 
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